Recent analysis provided by the Association of Medical Device Reprocessors (AMDR) indicates that US hospitals could save up to $2.28 billion a year by maximizing the use of reprocessed single-use medical devices. According to the report, in 2020, US hospitals saved $372 million just by reprocessing single-use medical devices, as reprocessed devices cost 25% to 40% less than new devices. These cost savings are in addition to the savings healthcare facilities accrue when reducing their processing of medical waste.
Key drivers in adopting single-use medical device reprocessing programs include cost savings, quality measures, and environmental impact. Reprocessing helps reduce waste sent to landfills, new medical device purchases, and waste removal costs. A recent study by the Fraunhofer Institute for Environmental, Safety, and Energy Technology found that using reprocessed medical devices can reduce the global warming impact of medical devices by 40%, ozone depletion by 90%, and the use of abiotic resources by 29%.
In addition to the $372 million in savings reported, the AMDR analysis showed that in the US, in 2020, over 9,000 healthcare facilities were using reprocessed medical devices, including all military hospitals and all US News & World Report Top Hospitals. In total, 31 million single-use medical devices were reprocessed in 2020, diverting 12 million pounds of medical waste from landfills.
According to the AMDR’s 2019 survey, 8,622 hospitals and ambulatory surgical centers reprocessed medical devices, diverting over 18 million pounds of medical waste and saving over $20 million in waste disposal costs. This created over $544 million in overall savings as well as over 2,000 jobs.
In addition to the environmental impact, another aspect of single-use medical device reprocessing that is top of mind for healthcare leadership is the quality of reprocessed devices. In many instances, reprocessed medical devices have been shown to be more reliable than new devices.
A 2015 study featured in the Journal of Medical Devices found Original Equipment Manufacturer (OEM) single-use bipolar and ultrasound diathermy devices to be defective 4.9 times more frequently than reprocessed devices, regardless of the manufacturer.
Single-use medical device reprocessing requires diverse resources and skilled technicians enabled by cutting-edge technology to reprocess the devices effectively. This creates a high barrier to protocol entry that hospitals cannot undertake on their own. With each step validated to standards recognized by the Food and Drug Administration (FDA), single-use medical device reprocessing includes cleaning, decontamination, refurbishing, testing, inspection, packaging, and sterilization.
Healthcare facilities are changing their reprocessing strategy for multiple reasons, including better adherence to industry laws and regulations, barriers to entry, and budgeting. Initially, many healthcare facilities began to strategize on single-use device reprocessing to comply with new laws and industry regulations, starting with the Medical Device User Fee and Modernization Act in 2002, which set defined standards for reusing single-use devices to provide better products and process oversight in line with existing OEM requirements.
Reprocessed medical devices also help the healthcare ecosystem by building resiliency in the supply chain to reduce shortages of critical medical devices. To effectively reprocess medical devices, some organizations have invested heavily in:
• developing manufacturing facilities that can support the process from collection to sterilization
• a skilled and well-trained workforce that can ensure the highest quality of reprocessing
• a robust support network that includes teams in the field to facilitate partner’s needs, national transportation and logistics infrastructure, and backend IT management to provide real-time data and access to program information.
Healthcare facilities considering a change in their single-use medical device reprocessing should consider a variety of factors when selecting a partner, including:
• manufacturing validation on every device to ensure it was properly reprocessed
• high-quality standards; adherence to International Organization for Standardization guidelines; and FDA clearances for a wide variety of devices to ensure that the reprocessed devices they receive will perform as well as possible
• registered FDA manufacturers with state-of-the-art facilities and technology to ensure quality, functionality, and sterility.
Medical device reprocessing is changing healthcare, not only in the OR and supply chain, but throughout a healthcare facility’s operations. As more studies are released demonstrating the effectiveness of reprocessed medical devices, and their impact on the environment and on a facility’s bottom line, there will be greater adoption of reprocessing programs, which will improve care delivery while reducing the environmental impact of healthcare.
This evolution has already begun, and the financial analysis provided by AMDR and the Fraunhofer Institute for Environmental, Safety, and Energy Technology demonstrates the opportunity medical device reprocessing offers to the healthcare industry. ORM
—Jake Colletti is national sales director for the renewal reprocessing division at Medline Industries, Inc. He has worked in the healthcare industry for over 25 years, holding local, regional, and national positions specific to medical device sales and capital equipment acquisition.